Abstract:OBJECTIVE:To evaluate the effects of hemoglobin (Hb) levels on long-term prognosis in the patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. METHODS:A total of 150 patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention between January 2005 to December 2007 were enrolled. They were divided into 2 groups: Hb < 120 g/L group (n = 21) and Hb ≥ 120 g/L group (n = 129). The mean clinical follow-up period was 3 years (range: 41.4 ± 16.1 months). The differences of major adverse cardiac events (MACE), including death, acute myocardial infarction, stent thrombosis & stent restenosis), were observed between two groups. RESULTS:The parameters of infarction site, infarction relative artery, 2-vessel disease, 3-vessel disease, Killip class ≥ II, drug-eluting stent, TIMI grade 3 flow, hypertension, hyperlipidemia, smoking, obesity, aspirin and clopidogrel use were not different between two groups (all P > 0.05). The rate of diabetes was significantly higher in Hb < 120 g/L group than that in Hb ≥ 120 g/L group (47.62% vs 18.60%, P = 0.0032). The mean age and symptom-onset-to balloon-time (SOTB) were significantly higher in Hb < 120 g/L group than that in Hb ≥ 120 g/L group (68.5 ± 9.2 vs 61.2 ± 12.2 years, P < 0.0001; 8.8 ± 10.5 vs 6.3 ± 5.0 h, P < 0.0001). The mean LVEF (left ventricular ejection fraction)(%) and rate of complete revascularization were significantly lower in Hb < 120 g/L group than that in Hb ≥ 120 g/L group (51.25 ± 11.34 vs 58.79 ± 10.38, P < 0.0001; 61.9% vs 86.8%, P = 0.0045). Logistic regression analysis showed that LVEF was an independent predictor of MACE during the follow-up period (P = 0.0140). During a 3-year follow-up, MACE occurred in 16 patients. The incidence of MACE was significantly higher in Hb < 120 g/L group than that in Hb ≥ 120 g/L group (33.33% vs 6.98%, P = 0.0003); Moreover the all-cause mortality and cardiac mortality were significantly higher in Hb < 120 g/L group than those in Hb ≥ 120 g/L group (28.57% vs 3.10%, P < 0.0001; 23.81% vs 2.33%, P < 0.0001). CONCLUSION:In the patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, hemoglobin level < 120 g/L at baseline is markedly associated with adverse outcomes and an elevated incidence of MACE and mortality during the follow-up period.

Correlation of Heart Function with Hemoglobin in Very Elderly Patients with Hypertension and Chronic Heart Failure

Correlation of Diastolic Blood Pressure with Hemoglobin and Hematocrit in Very Elderly Hypertensive Patients

Correlation of Heart Function with Plasma BNP and Serum Uric Acid Level in Elderly Heart Failure Patients

Study on the relationship between hemoglobin level and blood pressure in elderly subjects

Correlative research on the level of homocysteine and heart rate variability in senile hypertension patients

Analysis of the Relationship between Anemia and Heart Function in Patients with Chronic Heart Failure Caused by Coronary Heart Disease

Clinical evaluation of anemia patients with chronic heart failure

Role of anaerobic threshold in cardiac functional classification for NYHAⅠ-Ⅲ patients with chronic heart failure

Correlation between HE4 and cardiac function in chronic heart failure patients

Correlation Analysis of Hemoglobin-to-Red Blood Cell Distribution Width Ratio and Frailty in Elderly Patients With Coronary Heart Disease

Correlation of Serum Inflammatory Cytokines Levels with Cardiac Function in Elderly Patients with Heart Failure

Association Between Hemoglobin Level And Health Status In Elderly People Living In The Community In Beijing

Effects of Hemoglobin Levels on Long-Term Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Changes in peripheral blood CD14dimCD16+ monocyte count and serum C- reactive protein level in elderly patients with chronic heart failure

The study of the relativity between glycosylated hemoglob and chronic heart failure in diabetic patients

Correlation between Homocysteine and Cardiac Function in Patients with Coronary Heart Disease and Type 2 Diabetes

Relation Between Hemoglobin and Blood Pressure

Correlation research of left ventricualr hypertrophy and metabolic index in elderly male patients with hypertension

Influence of hemoglobin concentration on the in-hospital outcomes in newly diagnosed heart failure patients with atrial fibrillation: Finding from CCC-AF (improving care for cardiovascular disease in China-atrial fibrillation) project

Correlation among homocysteine, brain natriuretic peptide (BNP) and risk stratification of chronic heart failure

Correlation of plasma homocysteine levels with early mild diastolic heart failure in middle aged and elderly subjects